All publications

Export 168 results:
Author [ Title(Desc)] Type Year
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
M
Geretti AM, Sabin CA, Dunn DT, Nebbia G, UK HIV Drug Resistance Database and UK Collaborative HIV Cohort Study.  2005.  Mutations at reverse transcriptase (RT) codons G196, Q207, H208, R211 and I214 are associated with drug experience and specific RT mutation patterns. 14th International HIV Drug Resistance Workshop, 7-11 June 2005.
N
Croxford S, Chau C, Skingsley A, Tostevin A, Dolling D, Delpech V, UK HIV Drug Resistance Database.  2014.  National audit of baseline HIV resistance testing among newly-diagnosed adults. Third Joint Conference of BHIVA and BASHH, 1-14 April 2014.
White E, Smit E, Churchill D, Collins S, Booth C, Tostevin A, Sabin CA, Pillay D, Dunn DT, UK HIV Drug Resistance Database and UK Collaborative HIV Cohort Study.  2016.  No Effect of HIV-1 Subtype C on Virological Failure Rate with First-line TDF Regimens. International HIV Drug Resistance Workshop 2016.
White E, Smit E, Churchill D, Collins S, Booth C, Tostevin A, Sabin CA, Pillay D, Dunn DT, UK HIV Drug Resistance Database and UK Collaborative HIV Cohort Study.  2016.  No Effect of HIV-1 Subtype C on Virological Failure Rate with First-line TDF Regimens. Conference on Retroviruses and Opportunistic Infections (CROI) 2016.
White E, Smit E, Churchill D, Collins S, Booth C, Tostevin A, Sabin CA, Pillay D, Dunn DT, UK HIV Drug Resistance Database et al..  2016.  No evidence that HIV-1 subtype C infection compromises the efficacy of Tenofovir-containing: Cohort study in the United Kingdom. J Infect Dis.
Ragonnet-Cronin M, Lycett S, Hodcroft E, Hue S, Fearnhill E, Dunn DT, Delpech V, Leigh Brown A.  2013.  Non-B HIV transmission networks in the UK. 20th International HIV Dynamics & Evolution Conference, 8-11 May 2013.
Ragonnet-Cronin M, Hué S, Hodcroft EB, Tostevin A, Dunn D, Fawcett T, Pozniak A, Brown AE, Delpech V, Brown AJLeigh.  2018.  Non-disclosed men who have sex with men in UK HIV transmission networks: phylogenetic analysis of surveillance data.. Lancet HIV. 5(6):e309-e316.
Ragonnet-Cronin M, Hue S, Tostevin A, Pozniak A, Fawcett T, Brown A, Dunn DT, Leigh Brown A.  2017.  Nondisclosed MSM link together in HIV transmission networks. CROI.
Ragonnet-Cronin M, Hue S, Tostevin A, Pozniak A, Fawcett T, Brown A, Dunn DT, Leigh Brown A.  2017.  Nondisclosed MSM link together in HIV transmission networks. 24th International HIV Dynamics and Evolution.
Foster GM, Ambrose JC, Hue S, Delpech V, Fearnhill E, Abecasis AB, Leigh Brown A, Geretti AM.  2014.  Novel HIV-1 recombinants spreading across multiple risk groups in the United Kingdom: the identification and phylogeography of Circulating Recombinant Form (CRF) 50_A1D. PLoS One. 9:e83337.
Stirrup O, Dunn D.  2018.  Novel methodology to evaluate associations between baseline characteristics, CD4 response and viral failure on first-line ART for HIV. 22nd International Workshop on HIV and Hepatitis Observational Databases.
P
Dunn DT, UK HIV Drug Resistance Database.  2005.  Patterns of thymidine analogue mutations (TAMS) in samples sent for routine HIV drug resistance testing. 14th International HIV Drug Resistance Workshop, 7-11 June 2005.
Castro H, Pillay D, Cane P A, Asboe D, Cambiano V, Phillips AN, Dunn DT.  2013.  Persistence of HIV-1 transmitted drug resistance mutations. J Infect Dis. 208:1459-63.
Castro H, Dunn DT, Cane P A, Asboe D, Cambiano V, Phillips AN, Pillay D, UK HIV Drug Resistance Database.  2012.  Persistence of transmitted HIV drug resistance mutations. International Workshop on HIV & Hepatitis Virus Resistance and Curative Strategies, 5-9 June 2012. Antiviral Therapy 17 Suppl 1:A167.
Hughes GJ, Leigh Brown A, Bollback J, Rambaut A, Fearnhill E, Dunn DT, UK Collaborative Group on HIV Drug Resistance.  2009.  Phylodynamic analysis of non-B HIV in the United Kingdom reveals substantial post-immigration transmission but longer intervals between transmissions than for subtype B. 16th Conference on Retroviruses and Opportunistic Infections, February 2009.
Volz E, Le Vu S, Ratmann O, Tostevin A, Delpech V, Brown A, Gill NO, Fraser C.  2017.  Phylodynamic analysis to guide allocation of Pre-Exposure Prophylaxis in the United Kingdom. 24th International HIV Dynamics and Evolution.
Hue S, Brown A, Ragonnet-Cronin M, Lycett S, Dunn DT, Fearnhill E, Dolling D, Pozniak A, Pillay D, Delpech V et al..  2014.  Phylogenetic analyses reveal HIV-1 infections between men misclassified as heterosexual transmissions. AIDS. 28:1967-75.
Sethi G, Sabin CA, Lycett S, Ragonnet-Cronin M, Edwards SG, Fearnhill E, Dunn DT, Delpech V, Phillips AN, Pillay D et al..  2012.  Phylogenetic analysis of HIV transmission among different ethnic MSM groups in the UK. 19th Conference on Retroviruses and Opportunistic Infections, 5-8 March 2012.
Gifford RJM, de Oliveira T, Rambaut A, Pybus OG, Dunn DT, Vandamme A.M, Kellam P, Pillay D, UK HIV Drug Resistance Database.  2008.  Phylogenetic surveillance of viral genetic diversity and the evolving molecular epidemiology of human immunodeficiency virus type 1. 15th Conference on Retroviruses and Opportunistic Infections, February 2008.
Hue S, Fearnhill E, Dunn DT, Delpech V, Pillay D, Leigh Brown A, UK HIV Drug Resistance Database.  2011.  Phylogeographic and Risk Group Characteristics of HIV Subtype A Transmission in the UK. 18th Conference on Retroviruses and Opportunistic Infections, 27 Feb - 2 Mar 2011.